“Durable Efficacy of Certolizumab Pegol Dosed at 400 Mg Every Two Weeks Over 128 Weeks in Patients With Plaque Psoriasis Enrolled in Three Phase 3 Trials (CIMPASI-1, CIMPASI-2 and CIMPACT)”. 2020. SKIN The Journal of Cutaneous Medicine 4 (5): s45. https://doi.org/10.25251/skin.4.supp.45.